Abstract
A role for naturally occurring cytotoxic cells in immunosurveillance against malignancy has been presumed in several studies. The natural killer activity (NKA) of peripheral blood mononuclear cells was therefore measured at regular intervals in patients with acute leukaemia and expressed specific cytotoxicity. Sixty controls had a median NKA of 33.6% (range 15.4-71). Seventy-three patients with acute lymphoblastic leukaemia (ALL) and acute non-lymphoblastic leukaemia (ANLL) with untreated or relapsed disease had a median activity of 2.4% (range 0-13.4) (P less than 0.001), while 57 patients who had achieved complete remission had a median activity of 22.7% (range 9.5-64.4). In 15 patients, reductions of NKA were seen prior to 16 episodes of relapse. In ten of these (nine with ANLL and one with ALL), 11 relapses were preceded within 10 weeks by drops in NKA to less than 30% of remission levels. The median NKA of the group prior to the drop in activity was 25.5% and the median first low value was 6.0%. Five patients who relapsed after allogeneic bone marrow transplantation had significant, sustained drops in NKA, 5-9 weeks earlier. The median NKA prior to the drop was 25.6% and the median first low value was 8.0%. We therefore conclude that there was a marked reduction in NKA in patients with active acute leukaemia when compared with healthy blood donors and that this activity substantially improved in complete remission. All patients who relapsed had significantly reduced NKA which in some, significantly preceded the time of relapse. These data suggest that the regular assessment of NKA in patients with acute leukaemia may be a useful diagnostic tool.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andersson L. C., Nilsson K., Gahmberg C. G. K562--a human erythroleukemic cell line. Int J Cancer. 1979 Feb;23(2):143–147. doi: 10.1002/ijc.2910230202. [DOI] [PubMed] [Google Scholar]
- Bakács T., Gergely P., Cornain S., Klein E. Characterization of human lymphocyte subpopulations for cytotoxicity against tumor-derived monolayer cultures. Int J Cancer. 1977 Apr 15;19(4):441–449. doi: 10.1002/ijc.2910190402. [DOI] [PubMed] [Google Scholar]
- Balch C. M., Tilden A. B., Dougherty P. A., Cloud G. A. Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients. Ann Surg. 1983 Aug;198(2):192–199. doi: 10.1097/00000658-198308000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barada F. A., Jr, Kay H. D., Emmons R., Davis J. S., 4th, Horwitz D. A. Natural cytotoxicity of adherent cells from human blood: role of the Fc receptor. J Immunol. 1980 Aug;125(2):865–870. [PubMed] [Google Scholar]
- Bishop J. F., Joshua D. E., Lowenthal R. M., Kronenberg H., Whiteside M. G., Cobcroft R., Dodds A., Wolf M., Manoharan A. A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia. Aust N Z J Med. 1986 Feb;16(1):48–51. doi: 10.1111/j.1445-5994.1986.tb01115.x. [DOI] [PubMed] [Google Scholar]
- Brenner B. G., Friedman G., Margolese R. G. The relationship of clinical status and therapeutic modality to natural killer cell activity in human breast cancer. Cancer. 1985 Oct 1;56(7):1543–1548. doi: 10.1002/1097-0142(19851001)56:7<1543::aid-cncr2820560713>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
- Böyum A. A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field. Scand J Clin Lab Invest Suppl. 1968;97:51–76. [PubMed] [Google Scholar]
- Ching C., Lopez C. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody. Infect Immun. 1979 Oct;26(1):49–56. doi: 10.1128/iai.26.1.49-56.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dickinson A. M., Proctor S. J., Jacobs E., Reid M. M., Walker W., Craft A. W., Kernahan J. Natural killer cell activity in childhood acute lymphoblastic leukaemia in remission. Br J Haematol. 1985 Jan;59(1):45–53. doi: 10.1111/j.1365-2141.1985.tb02962.x. [DOI] [PubMed] [Google Scholar]
- Gastl G., Niederwieser D., Marth C., Huber H., Egg D., Schuler G., Margreiter R., Braunsteiner H., Huber C. Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states. Blood. 1984 Jul;64(1):288–295. [PubMed] [Google Scholar]
- Hajto T., Lanzrein C. Frequency of large granular lymphocytes in peripheral blood of healthy persons and breast cancer patients. Cancer Immunol Immunother. 1983;16(1):65–66. doi: 10.1007/BF00199908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
- Kay H. D., Bonnard G. D., West W. H., Herberman R. B. A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol. 1977 Jun;118(6):2058–2066. [PubMed] [Google Scholar]
- Kay N. E., Zarling J. M. Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells. Blood. 1984 Feb;63(2):305–309. [PubMed] [Google Scholar]
- Komiyama A., Yamada S., Kawai H., Miyagawa Y., Akabane T. Childhood acute lymphoblastic leukemia with natural killer activity. Clinical and cellular features of three cases. Cancer. 1984 Oct 15;54(8):1547–1553. doi: 10.1002/1097-0142(19841015)54:8<1547::aid-cncr2820540814>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
- Lanier L. L., Le A. M., Phillips J. H., Warner N. L., Babcock G. F. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol. 1983 Oct;131(4):1789–1796. [PubMed] [Google Scholar]
- Lotzová E., Savary C. A., Herberman R. B. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2. J Immunol. 1987 Apr 15;138(8):2718–2727. [PubMed] [Google Scholar]
- Mantovani A., Luini W., Peri G., Vecchi A., Spreafico F. Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice. J Natl Cancer Inst. 1978 Nov;61(5):1255–1261. doi: 10.1093/jnci/61.5.1255. [DOI] [PubMed] [Google Scholar]
- Matera L., Giancotti F. G. Natural killer activity and low-affinity E rosettes in acute leukemias. Acta Haematol. 1983;70(3):158–162. doi: 10.1159/000206716. [DOI] [PubMed] [Google Scholar]
- Paton C. M., Bishop J. F., Mathews J. D., Whiteside M. G. Immunotherapy maintenance in acute non-lymphocytic leukaemia. Aust N Z J Med. 1982 Dec;12(6):583–589. doi: 10.1111/j.1445-5994.1982.tb02642.x. [DOI] [PubMed] [Google Scholar]
- Ruco L. P., Procopio A., Maccallini V., Calogero A., Uccini S., Annino L., Mandelli F., Baroni C. D. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood. 1983 Jun;61(6):1132–1137. [PubMed] [Google Scholar]
- Rusthoven J. J. Clinical significance of natural killer cell cytotoxicity: need for proper data analysis in the design of clinical studies. Eur J Cancer Clin Oncol. 1985 Nov;21(11):1287–1293. doi: 10.1016/0277-5379(85)90305-0. [DOI] [PubMed] [Google Scholar]
- Storb R., Deeg H. J., Whitehead J., Appelbaum F., Beatty P., Bensinger W., Buckner C. D., Clift R., Doney K., Farewell V. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med. 1986 Mar 20;314(12):729–735. doi: 10.1056/NEJM198603203141201. [DOI] [PubMed] [Google Scholar]
- Stupp Y., Rosenkovitch E., Izak G. Natural killer activity in patients with acute myelocytic leukemia. Isr J Med Sci. 1978 Dec;14(12):1212–1215. [PubMed] [Google Scholar]
- Sørskaar D., Lie S. O., Førre O. Natural killer cell activity of peripheral blood and bone marrow mononuclear cells from patients with childhood acute lymphoblastic leukemia. Acta Paediatr Scand. 1985 May;74(3):433–437. doi: 10.1111/j.1651-2227.1985.tb10998.x. [DOI] [PubMed] [Google Scholar]
- Timonen T., Saksela E. Isolation of human NK cells by density gradient centrifugation. J Immunol Methods. 1980;36(3-4):285–291. doi: 10.1016/0022-1759(80)90133-7. [DOI] [PubMed] [Google Scholar]
- Tratkiewicz J. A., Szer J. Prediction of leukemic relapse soon after bone marrow transplantation. Transplant Proc. 1987 Feb;19(1 Pt 3):2648–2650. [PubMed] [Google Scholar]
- Trentin L., Pizzolo G., Feruglio C., Zambello R., Masciarelli M., Bulian P., Agostini C., Vinante F., Zanotti R., Semenzato G. Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission. Cancer. 1989 Aug 1;64(3):667–672. doi: 10.1002/1097-0142(19890801)64:3<667::aid-cncr2820640317>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
- Trinchieri G., Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med. 1978 May 1;147(5):1314–1333. doi: 10.1084/jem.147.5.1314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tursz T., Dokhelar M. C., Lipinski M., Amiel J. L. Low natural killer cell activity in patients with malignant lymphoma. Cancer. 1982 Dec 1;50(11):2333–2335. doi: 10.1002/1097-0142(19821201)50:11<2333::aid-cncr2820501119>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
- Yates J., Glidewell O., Wiernik P., Cooper M. R., Steinberg D., Dosik H., Levy R., Hoagland C., Henry P., Gottlieb A. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood. 1982 Aug;60(2):454–462. [PubMed] [Google Scholar]
- Ziegler H. W., Kay N. E., Zarling J. M. Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia. Int J Cancer. 1981 Mar 15;27(3):321–327. doi: 10.1002/ijc.2910270310. [DOI] [PubMed] [Google Scholar]
- Zöller M., Wigzell H. Normally occurring inhibitory cells for natural killer cell activity. I. Organ distribution. Cell Immunol. 1982 Nov 15;74(1):14–26. doi: 10.1016/0008-8749(82)90002-8. [DOI] [PubMed] [Google Scholar]